- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Cancer Metastatic in New Zealand
Total 8584 results
-
Hoffmann-La RocheCompleted
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
OBI Pharma, IncCompletedMetastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Gastric CancerTaiwan
-
Provectus PharmaceuticalsCompleted
-
Stony Brook UniversityThe University of Texas Health Science Center at San AntonioRecruitingMetastatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastasis | Spine Metastases | Metastatic Tumor | Metastatic Tumor of Bone | Metastatic Tumor to the SpineUnited States
-
General Oncology, Inc.Myriad Genetics, Inc.RecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV | Breast Cancer Stage IV | BRCA1 Mutation | BRCA2 Mutation | Pancreatic Acinar Cell Carcinoma | Metastatic Pancreatic Cancer | Breast Cancer Metastatic | HER2-negative Breast Cancer | Metastatic Pancreatic Ductal Adenocarcinoma and other conditionsUnited States
-
BriaCell Therapeutics CorporationRecruitingBreast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Breast Cancer Metastatic | End Stage CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Queens Cancer Center of Queens HospitalCompletedMetastatic Breast Cancer | Central Nervous System (CNS) MetastasesUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2/Neu-positive Breast CancerUnited States
-
BriaCell Therapeutics CorporationLumaBridgeEnrolling by invitationBreast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Breast Cancer MetastaticUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | ER+ Breast Cancer | Metastatic Breast Carcinoma | HER2+ Breast Cancer | Oligometastatic Breast CarcinomaUnited States
-
David Peereboom, MDNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic CancerUnited States
-
Artios Pharma LtdActive, not recruitingBreast Cancer | Metastatic Cancer | Advanced CancerUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
Gary SchwartzUniversity of Colorado, Denver; North Shore University HospitalTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMedImmune LLCCompletedMetastatic Breast CancerUnited States
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Breast CancerUnited States
-
Columbia UniversityNational Cancer Institute (NCI); Acetylon Pharmaceuticals IncorporatedCompletedMetastatic Breast Cancer | Breast CarcinomaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...CompletedMetastatic Breast CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
University of RochesterJohns Hopkins UniversityCompletedMetastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Indiana UniversityCompletedMetastatic Breast CancerUnited States
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Yale UniversityFoundation MedicineCompleted
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Dartmouth-Hitchcock Medical CenterHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterPfizerActive, not recruitingMetastatic Breast Cancer (MBC)United States
-
PfizerCompleted
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterSamus Therapeutics, Inc.CompletedMetastatic Breast CancerUnited States
-
Alaunos TherapeuticsCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedMetastatic Breast CancerUnited States
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareActive, not recruitingMetastatic HER2-Positive Breast CancerUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USATerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
PTC TherapeuticsUnited States Department of DefenseCompletedMetastatic Breast CancerUnited States
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Memorial Sloan Kettering Cancer CenterDuke UniversityCompleted